CD8A and metabolic dysfunction-associated steatotic liver disease: In addition, a randomized controlled study revealed that patients with NAFLD treated daily with Lactobacillus and Bifidobacterium species showed decreased levels of ALT and γGT, decreased counts of CD4+ T-cells and CD8+ T-cells, and improved HS fibrosis (87).